Andreas Wollenberg

1992–2025 年に発表

179
論文数
25,171
被引用数
81
h 指数
169
i10 指数

被引用数

Andreas Wollenberg の年別被引用数1993 年: 被引用 7 件1994 年: 被引用 13 件1995 年: 被引用 7 件1996 年: 被引用 10 件1997 年: 被引用 11 件1998 年: 被引用 14 件1999 年: 被引用 18 件2000 年: 被引用 26 件2001 年: 被引用 35 件2002 年: 被引用 30 件2003 年: 被引用 63 件2004 年: 被引用 62 件2005 年: 被引用 73 件2006 年: 被引用 58 件2007 年: 被引用 47 件2008 年: 被引用 94 件2009 年: 被引用 70 件2010 年: 被引用 70 件2011 年: 被引用 48 件2012 年: 被引用 82 件2013 年: 被引用 108 件2014 年: 被引用 90 件2015 年: 被引用 74 件2016 年: 被引用 111 件2017 年: 被引用 180 件2018 年: 被引用 234 件2019 年: 被引用 854 件2020 年: 被引用 1,049 件2021 年: 被引用 1,231 件2022 年: 被引用 943 件2023 年: 被引用 958 件2024 年: 被引用 1,398 件2025 年: 被引用 806 件2026 年: 被引用 9 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,771 件、この内訳の 19.6%ドイツ: 引用元論文 877 件、この内訳の 9.7%イギリス: 引用元論文 562 件、この内訳の 6.2%イタリア: 引用元論文 488 件、この内訳の 5.4%フランス: 引用元論文 442 件、この内訳の 4.9%日本: 引用元論文 442 件、この内訳の 4.9%中国: 引用元論文 416 件、この内訳の 4.6%カナダ: 引用元論文 345 件、この内訳の 3.8%スイス: 引用元論文 310 件、この内訳の 3.4%オランダ: 引用元論文 300 件、この内訳の 3.3%デンマーク: 引用元論文 269 件、この内訳の 3%スペイン: 引用元論文 258 件、この内訳の 2.8%
0%19.6%その他 28.4%

分野

  • Medicine78.5%
  • Immunology and Microbiology11.6%
  • Biochemistry, Genetics and Molecular Biology6.5%
  • Pharmacology, Toxicology and Pharmaceutics0.9%
  • Neuroscience0.6%
  • Agricultural and Biological Sciences0.4%
  • その他1.5%

トピック

  • Dermatology and Skin Diseases22.4%
  • Allergic Rhinitis and Sensitization10.7%
  • Asthma and respiratory diseases8.1%
  • Psoriasis: Treatment and Pathogenesis7.1%
  • Food Allergy and Anaphylaxis Research4.2%
  • Urticaria and Related Conditions4%
  • その他43.5%

共著者

全論文

検索で開く
  1. Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2016 被引用: 2,045

  2. Tralokinumab for moderate‐to‐severe atopic dermatitis: results from two 52‐week, randomized, double‐blind, multicentre, placebo‐controlled phase III trials (ECZTRA 1 and ECZTRA 2)*

    著者: , , , , , , , , , , , , , , , , , , , , , , - British Journal of Dermatology 2020 被引用: 595

  3. European guideline (EuroGuiDerm) on atopic eczema: part I – systemic therapy

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jacek C. Szepietowski, Antonio Torrelo, Thomas Werfel, Carsten Flohr - Journal of the European Academy of Dermatology and Venereology 2022 被引用: 406

  4. Consensus‐based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I

    著者: , , , , , , , , , , , , , , , , , , , - Journal of the European Academy of Dermatology and Venereology 2018 被引用: 1,175

  5. Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis: a randomised, double-blind, placebo-controlled, phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David J. Cohen, David M. Pariser, Elaine C. Siegfried, Eric L. Simpson, Jeffrey Leflein, Jeffrey S. Weinberg, John Browning, Joyce Teng, Lara Wine Lee, Lawrence Sher, Lucia Z. Diaz, Lynda C. Schneider, Mercedes E. González, Ned T. Rupp, Peck Y. Ong, Robert Cartwright, Robert Sidbury, Weily Soong, Andreas Pinter, Andreas Wollenberg, Christina Schnopp, Michael J. Cork, Peter D. Arkwright, Anna Korkosz, Dorota Bystrzanowska, Ewa Sygula, Jacek Zdybski, Kamila Padlewska - The Lancet 2022 被引用: 264

  6. ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of the European Academy of Dermatology and Venereology 2020 被引用: 465

  7. Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: A randomized, double-blinded, placebo-controlled phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Journal of the American Academy of Dermatology 2020 被引用: 389

  8. Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

    著者: , , , , , , , , , , , , , , , , - The Lancet 2020 被引用: 491

  9. European guideline (EuroGuiDerm) on atopic eczema – part II: non‐systemic treatments and treatment recommendations for special AE patient populations

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jacek C. Szepietowski, Antonio Torrelo, Thomas Werfel, Carsten Flohr - Journal of the European Academy of Dermatology and Venereology 2022 被引用: 266

  10. Conjunctivitis in dupilumab clinical trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - British Journal of Dermatology 2019 被引用: 422

  11. Efficacy and Safety of Tralokinumab in Adolescents With Moderate to Severe Atopic Dermatitis

    著者: , , , , , , , , , , , , , , , - JAMA Dermatology 2023 被引用: 137

  12. Cellular and molecular immunologic mechanisms in patients with atopic dermatitis

    著者: , , , , , , , , , , , , , , - Journal of Allergy and Clinical Immunology 2016 被引用: 589

  13. Efficacy and Safety of Lebrikizumab in Combination With Topical Corticosteroids in Adolescents and Adults With Moderate-to-Severe Atopic Dermatitis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ricardo Tan, Francis J Averill, Rosalyn Elizabeth George, Eddie Armas, Benjamin Lockshin, Jennifer Soung, Walter K. Nahm, Alison Ehrlich, Sunil Dhawan, Eric L. Simpson, Steve Sitar, Jerry Bagel, Phoebe Rich, Bruce Torkan, David F Fivenson, Jamie Weisman, Melody Lynn Stone, April W. Armstrong, Mirwais Saifi, Brad Glick, Melinda Gooderham, Isaiah Day, Lorne Albrecht, Marni Wiseman, David Gratton, Chi-ho Hong, Bernadetta Majorek‐Olechowska, Adam Reich, Beata Kręcisz, Irena Walecka-Herniczek, Jolanta Węgłowska, Beata Bergler‐Czop, Boguslawa Cimoszko, Kamila Padlewska, Maria Czubek, Andreas Pinter, Kristian Reich, Thomas Wildfeuer, Roland Aschoff - JAMA Dermatology 2023 被引用: 143

  14. Consensus‐based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II

    著者: , , , , , , , , , , , , , , , , , , , - Journal of the European Academy of Dermatology and Venereology 2018 被引用: 687

  15. Treatment of atopic dermatitis with tralokinumab, an anti–IL-13 mAb

    著者: , , , , , , , - Journal of Allergy and Clinical Immunology 2018 被引用: 421

  16. Anti–Interleukin-31 Receptor A Antibody for Atopic Dermatitis

    著者: , , , , , , , , , , , - New England Journal of Medicine 2017 被引用: 587

  17. Baricitinib in patients with moderate‐to‐severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phaseIIItrials

    著者: , , , , , , , , , , , , , , , , , , , , , , , - British Journal of Dermatology 2020 被引用: 379

  18. Trial of Nemolizumab in Moderate-to-Severe Prurigo Nodularis

    著者: , , , , , , , , , , , - New England Journal of Medicine 2020 被引用: 277

  19. Phase 2B randomized study of nemolizumab in adults with moderate-to-severe atopic dermatitis and severe pruritus

    著者: , , , , , , , , , , , - Journal of Allergy and Clinical Immunology 2019 被引用: 271

  20. The role of bacterial skin infections in atopic dermatitis: expert statement and review from the International Eczema Council Skin Infection Group

    著者: , , , , , , , , , , , , , , , - British Journal of Dermatology 2019 被引用: 214

  21. Safety of tralokinumab in adult patients with moderate-to-severe atopic dermatitis: pooled analysis of five randomized, double-blind, placebo-controlled phase II and phase III trials

    著者: , , , , , , , , , , , , - British Journal of Dermatology 2022 被引用: 74

  22. Long-term 2-year safety and efficacy of tralokinumab in adults with moderate-to-severe atopic dermatitis: Interim analysis of the ECZTEND open-label extension trial

    著者: , , , , , , , , , , , , , , , , - Journal of the American Academy of Dermatology 2022 被引用: 75

  23. European academy of dermatology and venereology European prurigo project: expert consensus on the definition, classification and terminology of chronic prurigo

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Franz J. Legat, Sonja Ständer, EADV Task Force Pruritus group members - Journal of the European Academy of Dermatology and Venereology 2017 被引用: 265

  24. Nemolizumab with concomitant topical therapy in adolescents and adults with moderate-to-severe atopic dermatitis (ARCADIA 1 and ARCADIA 2): results from two replicate, double-blind, randomised controlled phase 3 trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet 2024 被引用: 125